TABLE 1.
LUNG ABNORMALITIES IN Itgb6−/− MICE DUE TO LACK OF TGF-β
Process | Description | Reference |
---|---|---|
Inflammation | Activated lymphocytes around airways and vessels; similar to lesions in Tgfb1−/− mice | (14) |
Fibrosis | Protection from bleomycin-induced lung fibrosis | (9) |
Acute lung injury | Reduced capillary leak after bleomycin-induced lung injury | (18) |
Emphysema | Late onset emphysema due to excess MMP12 production by alveolar macrophages | (16) |
EMT | Alveolar epithelial type 2 cells cultured on fibronectin undergo EMT due to αvβ6-mediated TGF-β activation | (19) |
Alveolar macrophage function | αvβ6-mediated TGF-β activation inhibits alveolar macrophage functionality; inhibition can be overridden by Toll-like receptor signaling | (20) |
Surfactant homeostasis | αvβ6-mediated TGF-β activation is required for normal surfactant homeostasis, probably via effects on alveolar macrophage-mediated surfactant catabolism | (23) |
Definition of abbreviations: EMT, epithelial-mesenchymal transition; TGF-β, transforming growth factor-β.